Given its current priorities, the Company decided to put on hold the development of M1Pram and will continue to evaluate the path forward for M1Pram as the type 1 diabetes treatment landscape continues to evolve
Rest periods allow sensitivity to normalize
No human clinical trials have evaluated AOD-9604 for osteoarthritis yet, so discuss the current evidence honestly with your provider before pursuing this specific application
The July 2026 PCAC review may expand regulated compounding access and establish clearer quality frameworks
[DOI] [PubMed] [Google Scholar] 79.Pevec D, Novinscak T, Brcic L, Sipos K, Jukic I, Staresinic M, et al
Luckily, vitamin B12 can be easily supplemented with B12 shots